Michael Andrew Gillespie
Direktor/Vorstandsmitglied bei Glixogen Therapeutics Ltd.
Aktive Positionen von Michael Andrew Gillespie
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | 08.06.2022 | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Private Equity Investor | 01.06.2020 | - |
Karriereverlauf von Michael Andrew Gillespie
Statistik
International
| Israel | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| Private Equity Investor | 1 |
Sektoral
| Commercial Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
